Replimune (REPL) Current Leases (2019 - 2025)
Replimune's (REPL) quarterly Current Leases came in at $2.9 million in Q4 2025, up 2.99% year-on-year from $2.8 million in Q4 2024, and up 136.53% quarter-over-quarter from $1.2 million in Q3 2025.
Replimune (REPL) Current Leases (2019 - 2025) Analysis & Trends
Replimune has disclosed Current Leases across 7 years of filings, most recently posting $2.9 million for Q4 2025.
- Current Leases for Q4 2025 came in at $2.9 million, up 2.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 million (up 2.99% YoY), and the FY2025 annual result was $2.8 million, up 2.98% from the prior year.
- Current Leases came in at $2.9 million for Q4 2025 at Replimune, up from $1.2 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.9 million in Q4 2025 to a low of $967000.0 in Q3 2021.
- The 5-year median for Current Leases is $2.6 million (2021), against an average of $2.0 million.
- Across the five-year window, Current Leases soared 184.88% in 2021 and tumbled 56.98% in 2022, its largest moves.
- Replimune's Current Leases stood at $2.5 million in 2021, then increased by 2.99% to $2.6 million in 2022, then advanced by 3.02% to $2.7 million in 2023, then advanced by 3.0% to $2.8 million in 2024, then grew by 2.99% to $2.9 million in 2025.
- The last three Current Leases figures came in at $2.9 million (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | 2.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.86 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 2.78 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 2.74 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 2.66 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 2.62 Mn |
| Sep 30, 2022 | 2.60 Mn |
| Jun 30, 2022 | 2.58 Mn |
| Mar 31, 2022 | 1.07 Mn |
| Dec 31, 2021 | 2.54 Mn |
| Sep 30, 2021 | 967,000.00 |
| Jun 30, 2021 | 975,000.00 |
| Mar 31, 2021 | 2.49 Mn |